日本の生物製剤市場レポート供給源別(微生物、哺乳類、その他)、製品別(モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi・分子療法、その他)、疾患別(腫瘍学、免疫障害、循環器障害、血液障害、その他)、製造別(委託製造、自社製造)、地域別 2025-2033

日本の生物製剤市場レポート供給源別(微生物、哺乳類、その他)、製品別(モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi・分子療法、その他)、疾患別(腫瘍学、免疫障害、循環器障害、血液障害、その他)、製造別(委託製造、自社製造)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A27543

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Biologics Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Biologics Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   Japan Biologics Market - Breakup by Source
    6.1    Microbial
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Forecast (2025-2033)
    6.2    Mammalian
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Forecast (2025-2033)
    6.3    Others
        6.3.1 Historical and Current Market Trends (2019-2024)
        6.3.2 Market Forecast (2025-2033)
7   Japan Biologics Market - Breakup by Product
    7.1    Monoclonal Antibodies
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)
        7.1.3 Market Forecast (2025-2033)
    7.2    Vaccines
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024)
        7.2.3 Market Forecast (2025-2033)
    7.3    Recombinant Proteins
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (2019-2024)
        7.3.3 Market Forecast (2025-2033)
    7.4    Antisense, RNAi and Molecular Therapy
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (2019-2024)
        7.4.3 Market Forecast (2025-2033)
    7.5    Others
        7.5.1 Historical and Current Market Trends (2019-2024)
        7.5.2 Market Forecast (2025-2033)
8   Japan Biologics Market - Breakup by Disease
    8.1    Oncology
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Forecast (2025-2033)
    8.2    Immunological Disorders
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Forecast (2025-2033)
    8.3    Cardiovascular Disorders
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2019-2024)
        8.3.3 Market Forecast (2025-2033)
    8.4    Hematological Disorders
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2019-2024)
        8.4.3 Market Forecast (2025-2033)
    8.5    Others
        8.5.1 Historical and Current Market Trends (2019-2024)
        8.5.2 Market Forecast (2025-2033)
9   Japan Biologics Market - Breakup by Manufacturing
    9.1    Outsourced
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2019-2024)
        9.1.3 Market Forecast (2025-2033)
    9.2    In-House
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2019-2024)
        9.2.3 Market Forecast (2025-2033)
10  Japan Biologics Market – Breakup by Region 
    10.1    Kanto Region
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2019-2024)
        10.1.3 Market Breakup by Source
        10.1.4 Market Breakup by Product
        10.1.5 Market Breakup by Disease
        10.1.6 Market Breakup by Manufacturing
        10.1.7 Key Players
        10.1.8 Market Forecast (2025-2033)
    10.2    Kansai/Kinki Region
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2019-2024)
        10.2.3 Market Breakup by Source
        10.2.4 Market Breakup by Product
        10.2.5 Market Breakup by Disease
        10.2.6 Market Breakup by Manufacturing
        10.2.7 Key Players
        10.2.8 Market Forecast (2025-2033)
    10.3    Central/ Chubu Region
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (2019-2024)
        10.3.3 Market Breakup by Source
        10.3.4 Market Breakup by Product
        10.3.5 Market Breakup by Disease
        10.3.6 Market Breakup by Manufacturing
        10.3.7 Key Players
        10.3.8 Market Forecast (2025-2033)
    10.4    Kyushu-Okinawa Region
        10.4.1 Overview
        10.4.2 Historical and Current Market Trends (2019-2024)
        10.4.3 Market Breakup by Source
        10.4.4 Market Breakup by Product
        10.4.5 Market Breakup by Disease
        10.4.6 Market Breakup by Manufacturing
        10.4.7 Key Players
        10.4.8 Market Forecast (2025-2033)
    10.5    Tohoku Region
        10.5.1 Overview
        10.5.2 Historical and Current Market Trends (2019-2024)
        10.5.3 Market Breakup by Source
        10.5.4 Market Breakup by Product
        10.5.5 Market Breakup by Disease
        10.5.6 Market Breakup by Manufacturing
        10.5.7 Key Players
        10.5.8 Market Forecast (2025-2033)
    10.6    Chugoku Region
        10.6.1 Overview
        10.6.2 Historical and Current Market Trends (2019-2024)
        10.6.3 Market Breakup by Source
        10.6.4 Market Breakup by Product
        10.6.5 Market Breakup by Disease
        10.6.6 Market Breakup by Manufacturing
        10.6.7 Key Players
        10.6.8 Market Forecast (2025-2033)
    10.7    Hokkaido Region
        10.7.1 Overview
        10.7.2 Historical and Current Market Trends (2019-2024)
        10.7.3 Market Breakup by Source
        10.7.4 Market Breakup by Product
        10.7.5 Market Breakup by Disease
        10.7.6 Market Breakup by Manufacturing
        10.7.7 Key Players
        10.7.8 Market Forecast (2025-2033)
    10.8    Shikoku Region
        10.8.1 Overview
        10.8.2 Historical and Current Market Trends (2019-2024)
        10.8.3 Market Breakup by Source
        10.8.4 Market Breakup by Product
        10.8.5 Market Breakup by Disease
        10.8.6 Market Breakup by Manufacturing
        10.8.7 Key Players
        10.8.8 Market Forecast (2025-2033)
11  Japan Biologics Market – Competitive Landscape
    11.1    Overview
    11.2    Market Structure
    11.3    Market Player Positioning
    11.4    Top Winning Strategies
    11.5    Competitive Dashboard
    11.6    Company Evaluation Quadrant
12  Profiles of Key Players
    12.1    Company A 
        12.1.1 Business Overview
        12.1.2 Product Portfolio
        12.1.3 Business Strategies
        12.1.4 SWOT Analysis
        12.1.5 Major News and Events
    12.2    Company B
        12.2.1 Business Overview
        12.2.2 Product Portfolio
        12.2.3 Business Strategies
        12.2.4 SWOT Analysis
        12.2.5 Major News and Events
    12.3    Company C
        12.3.1 Business Overview
        12.3.2 Product Portfolio
        12.3.3 Business Strategies
        12.3.4 SWOT Analysis
        12.3.5 Major News and Events
    12.4    Company D 
        12.4.1 Business Overview
        12.4.2 Product Portfolio
        12.4.3 Business Strategies
        12.4.4 SWOT Analysis
        12.4.5 Major News and Events
    12.5    Company E
        12.5.1 Business Overview
        12.5.2 Product Portfolio
        12.5.3 Business Strategies
        12.5.4 SWOT Analysis
        12.5.5 Major News and Events
    
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

13  Japan Biologics Market - Industry Analysis
    13.1    Drivers, Restraints, and Opportunities
        13.1.1 Overview
        13.1.2 Drivers
        13.1.3 Restraints
        13.1.4 Opportunities
    13.2   Porters Five Forces Analysis
        13.2.1 Overview
        13.2.2 Bargaining Power of Buyers
        13.2.3 Bargaining Power of Suppliers
        13.2.4 Degree of Competition
        13.2.5 Threat of New Entrants
        13.2.6 Threat of Substitutes
    13.3    Value Chain Analysis
14  Appendix

日本の生物製剤市場レポート供給源別(微生物、哺乳類、その他)、製品別(モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi・分子療法、その他)、疾患別(腫瘍学、免疫障害、循環器障害、血液障害、その他)、製造別(委託製造、自社製造)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials